On Jul. 20, 2020, BioReference Laboratories, an OPKO Health company, announced accepted an Indefinite Delivery Indefinite Quantity contract…
On Jul. 20, 2020, BioNTech and Pfizer announced initial data from their ongoing German Phase 1/2, open-label, non-randomized,…
On Jul. 20, 2020, Sorrento announced that it had entered into a binding term sheet for an exclusive…
On Jul. 20, 2020, Valneva confirmed its participation in the UK government COVID-19 vaccine response program. Valneva had…
On Jul. 20, 2020, Oxford Immunotec announced that it had entered into a long-term agreement to supply its…
On Jul. 20, 2020, Innovation Pharma reported receiving new data from ongoing lab testing being conducted at a…
On Jul. 20, 2020, Pfizer and BioNTech announced an agreement with the United Kingdom to supply 30 million…
On Jul. 20, 2020, Mateon Therapeutics announced the launch of its global observational study called ARTI-19, for Artemisinin…
On Jul. 20, 2020, scientists at HDT Bio, PAI Life Sciences, and the University of Washington announced they…
On Jul. 20, 2020, Luminex announced the FDA had issued an Emergency Use Authorization for the company’s xMAPﾮ…
On Jul. 20, 2020, Thermo Fisher Scientific expanded global capacity and capabilities across its leading pharma services network…
On Jul. 20, 2020, AstraZeneca announced that Interim results from the ongoing Phase I/II COV001 trial, led by…
On Jul. 20, 2020, interim results from the ongoing Phase I/II COV001 trial, led by Oxford University, showed…
On Jul. 20, 2020, a scientific analysis of more than 2,000 brain scans found evidence for highly reproducible…
On Jul. 20, 2020, the Serum Institute of India (SII) announced that with the trials of the COVID-19…
On Jul. 19, 2020, HDT Bio announced co-development efforts with Gennova Biopharmaceuticals to start evaluating HDT-301, a COVID-19…
On Jul. 18, 2020, a Health Trendsﾙ study from researchers at Quest Diagnostics and the University of Pittsburgh…
On Jul. 18, 2020, the FDA reissued an emergency use authorization (EUA) to Quest Diagnostics to authorize its…
On Jul. 16, 2020, Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC;…
On Jul. 16, 2020, RedHill Biopharma announced approval from the Ministry of Health of the Russian Federation for…
On Jul. 16, 2020, Catalent and Humanigen announced the expansion of their relationship, under which Catalent will provide…
On Jul. 16, 2020, Heron Therapeutics announced initiation of the GUARDS-1 Study, a Phase 2 clinical study evaluating…
On Jul. 16, 2020, Codex DNA announced the release of a new synthetic SARS-CoV-2 genome developed to accelerate…
On Jul. 16, 2020, the Tufts Center for the Study of Drug Development reported that although regulatory approval…
On Jul. 16, 2020, Atossa Therapeutics announced that it has contracted with Avance Clinical to conduct a clinical…
On Jul. 16, 2020, Tonix Pharmaceuticals announced it had entered into a research collaboration and option agreement with…
On Jul. 16, 2020, Dynavax Technologies and the Icahn School of Medicine at Mount Sinai announced they had…
On Jul. 15, 2020, bioMerieux announced that the BIOFIRE Respiratory Panel 2.1 plus (RP2.1plus) was CE marked. The…
On Jul. 15, 2020, A new Cleveland Clinic study identified genetic factors that may influence susceptibility to COVID-19….
On Jul. 15, 2020, Atossa Therapeutics announced successful results from in vitro testing of AT-301, Atossa’s proprietary COVID-19…